Assessing the clinical and economic impact of delayed versus early pegaspargase
Journal of Oncology Pharmacy Practice
Published online on October 30, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundIn acute lymphoblastic leukemia (ALL), pegaspargase is included in the backbone of numerous chemotherapy regimens. Treatment-related toxicities can be substantial, often resulting in treatment delays, dose reductions, or early discontinuation. ...
BackgroundIn acute lymphoblastic leukemia (ALL), pegaspargase is included in the backbone of numerous chemotherapy regimens. Treatment-related toxicities can be substantial, often resulting in treatment delays, dose reductions, or early discontinuation. ...